Workflow
非那雄胺喷雾剂
icon
Search documents
掘金新消费 - 医美产业链动态更新
2025-07-11 01:13
Summary of the Medical Aesthetics Industry Conference Call Industry Overview - The Chinese medical aesthetics market has a penetration rate of only about 4%, significantly lower than South Korea's 20%, indicating substantial growth potential [2][4] - The market is still in its early stages, with a lack of standardization and a mix of formal and informal institutions [2][4] Key Insights and Arguments - The rise of "light medical aesthetics" is seen as a future direction due to its lower entry barriers and ease of replication, with service frequency increasing from 30% to 70% post-pandemic, and an expected market size of 140 billion RMB [1][4] - New Oxygen's pre-discount model may disrupt traditional institutions, which face high customer acquisition costs and intense price competition [1][4] - New Oxygen has optimized its single-store model, increasing traditional store profit margins from less than 5% to 15% by reducing customer acquisition costs and adopting a light medical aesthetics small store model [1][6][9] Company Strategies - New Oxygen is implementing a simulated chain model that minimizes reliance on doctor IP, establishing a centralized platform for marketing, product development, and supply chain management [9] - The company plans to increase its store count to over 50 by the end of the year and is opening up franchising opportunities to rapidly replicate its light asset model [9] - New Oxygen has invested over 1 billion RMB in upstream supply chain integration, with plans to launch more proprietary products [10] Market Dynamics - The medical aesthetics industry is shifting towards a volume-based model, focusing on bulk sales and affordability through standardized operations and quality service to enhance customer retention [3][11] - The average customer acquisition cost in the industry is around 2000 RMB, with traditional institutions facing high operational costs due to a lack of standardization and high marketing expenses [5][6] Competitive Landscape - Four Ring Pharmaceutical is expected to contribute new revenue streams with products like the "Youthful Needle" and "Girl Needle," targeting a sales goal of 1 billion RMB for its botulinum toxin product [3][13] - Kedi has launched a finasteride spray, anticipating peak sales of at least 1 billion RMB, enhancing its competitive position in the hair loss market [14] - Huadong Pharmaceutical has introduced high-end hyaluronic acid products, with expectations of significant sales growth [15] Future Outlook - The light medical aesthetics market in China is projected to accommodate over a thousand stores, with potential revenues of 40 billion RMB and profits of 6 billion RMB if the market penetrates effectively [12] - The overall sentiment in the medical aesthetics sector is improving, with increased attention and potential for further developments in the third quarter of 2025 [19]
美护商社行业周报:孩子王小商品城25H1业绩预增,MINISOLAND全球壹号店开业9个月业绩破亿-20250707
Guoyuan Securities· 2025-07-07 11:42
Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][32]. Core Insights - The beauty care sector saw significant activity, with Douyin's beauty category GMV exceeding 20 billion yuan in June, where skincare accounted for 66.4% and color cosmetics for 33.6% [3][24]. - Notable companies like MINISO achieved over 100 million yuan in sales within nine months of opening their global flagship store [4][29]. - The report highlights the performance of key companies, with projected net profits for Xiaoshangpin City expected to be between 1.63 billion to 1.7 billion yuan, marking a year-on-year increase of 12.57% to 17.40% [30]. Market Performance - During the week of June 30 to July 4, 2025, the retail trade, social services, and beauty care sectors experienced declines of 0.16%, 0.74%, and 0.55% respectively, ranking 27th, 17th, and 29th among 31 primary industries [14][18]. - The report notes that the education, professional chain, and trade sectors saw the highest gains, with increases of 7.47%, 7.42%, and 5.2% respectively [2][14]. Key Industry Events and News - The report discusses various industry events, including the approval of a topical finasteride spray by NMPA, marking it as the first and only approved product for male androgenetic alopecia [3][24]. - L'Oréal announced the acquisition of the professional hair care brand Color Wow, valued at approximately 10 billion yuan [3][26]. - The report also mentions the performance of companies like Huaxi Biological, which reported significant revenue declines for its brands in 2024 [31]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzhi Biological, Marubi Biological, and others within the beauty care sector [5][32].